Clinical Trials
8
Trial Phases
4 Phases
Drug Approvals
7
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
A Phase 4 Study to Evaluate Adrenal Function in Hypogonadal Men Treated With JATENZO® for 12 Months
- First Posted Date
- 2024-04-26
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Tolmar Inc.
- Target Recruit Count
- 110
- Registration Number
- NCT06385509
- Locations
- 🇺🇸
Alliance for Multispecialty Research, Norfolk, Virginia, United States
🇺🇸Clinical Trials Research, Lincoln, California, United States
🇺🇸Long Beach Research Institute, LLC, Long Beach, California, United States
Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2022-12-09
- Last Posted Date
- 2025-06-22
- Lead Sponsor
- Tolmar Inc.
- Target Recruit Count
- 250
- Registration Number
- NCT05645536
- Locations
- 🇺🇸
Texas Oncology - Presbyterian Cancer Center, Dallas, Texas, United States
🇦🇷Sanatorio Allende, Cordoba, Argentina
🇧🇷Centro de Estudos e Pesquisa de Hematologia e Oncologia, Santo André, Brazil
Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2021-05-28
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- Tolmar Inc.
- Target Recruit Count
- 250
- Registration Number
- NCT04906395
- Locations
- 🇺🇸
Marin Cancer Care, Inc, Greenbrae, California, United States
🇺🇸Cypress Hematology and Oncology, Parker, Colorado, United States
🇺🇸Mount Sinai Hospital, Chicago, Illinois, United States
BE Study of Calcipotriene Hydrate and Betamethasone Dipropionate Topical Suspension in the Treatment of Scalp Psoriasis
- Conditions
- Scalp Psoriasis
- Interventions
- First Posted Date
- 2017-04-20
- Last Posted Date
- 2018-03-07
- Lead Sponsor
- Tolmar Inc.
- Target Recruit Count
- 699
- Registration Number
- NCT03122353
- Locations
- 🇺🇸
Site 17, Hot Springs, Arkansas, United States
🇺🇸Site 29, Fremont, California, United States
🇺🇸Site 12, Los Angeles, California, United States
Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty
- First Posted Date
- 2015-05-25
- Last Posted Date
- 2020-06-02
- Lead Sponsor
- Tolmar Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT02452931
- Locations
- 🇺🇸
University of California, San Diego, San Diego, California, United States
🇺🇸Joe DiMaggio Children's Hospital, Hollywood, Florida, United States
🇺🇸Nemours Children's Clinic, Jacksonville, Florida, United States